✦ LIBER ✦

Current Status of Adjuvant Chemotherapy for Stage IB Non–Small-Cell Lung Cancer: Implications for the New Intergroup Trial

✍ Scribed by Heather A. Wakelee; Joan H. Schiller; David R. Gandara

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant chemotherapy for resected non-s

✍ Christopher G Azzoli 📂 Article 📅 2006 🏛 The Lancet 🌐 English ⚖ 81 KB

Propensity score–matched analysis of adj

✍ Tsutani, Yasuhiro; Miyata, Yoshihiro; Kushitani, Kei; Takeshima, Yukio; Yoshimur 📂 Article 📅 2014 🏛 CTSNet 🌐 English ⚖ 651 KB

The Optimal Chemotherapy for Stage III N

✍ Shirish M. Gadgeel 📂 Article 📅 2011 🏛 Current Science Inc. 🌐 English ⚖ 146 KB

Pharmacogenomic Approaches to Individual

✍ Oliver Gautschi; Philip C. Mack; Angela M. Davies; David M. Jablons; Rafael Rose 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 855 KB

Adjuvant chemotherapy for non-small cell

✍ Aynsley, E.; Clark, S.; Black, F.; Gardiner, J.; Mulvenna, P. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Individualizing Chemotherapy for Non-sma

✍ George R. Simon 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 383 KB